NCT06959004View on ClinicalTrials.gov

Substance P-Induced Migraine Attacks Without Aura

NARecruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 13, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

December 1, 2026

Conditions
Migraine
Interventions
DRUG

Substance P

The participants will receive a continuous intravenous infusion of 20 mL of substance P (4.0 pmol/kg/min) over 20 minutes.

DRUG

Placebo

The participants will receive a continuous intravenous infusion of 20 mL of placebo (isotonic saline) over 20 minutes.

Trial Locations (1)

2600

RECRUITING

Rigshospitalet Glostrup, Glostrup Municipality

All Listed Sponsors
lead

Danish Headache Center

OTHER